Medline ® Abstract for Reference 20
of 'Epidemiology and pathogenesis of the polycystic ovary syndrome in adults'
20
TI
Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes.
AU
Peppard HR, Marfori J, Iuorno MJ, Nestler JE
SO
Diabetes Care. 2001;24(6):1050.
OBJECTIVE:
Women with polycystic ovary syndrome (PCOS) have an increased risk for developing type 2 diabetes. Few studies have assessed women with type 2 diabetes to determine the frequency of PCOS in this population.
RESEARCH DESIGN AND METHODS:
To determine the prevalence of PCOS among premenopausal women with type 2 diabetes, we conducted a retrospective cross-sectional prevalence study. We reviewed the medical records of all women seen in the Diabetes Clinic of the Medical College of Virginia Hospitals between January 1995 through February 2000. A diagnosis of PCOS was based on 1) oligomenorrhea, 2) hyperandrogenism (biochemical or clinical), and 3) exclusion of other related disorders.
RESULTS:
We reviewed the medical records of 618 women with diabetes and identified 47 women eligible for study. Of the 47 women, 30 consented to an evaluation. Of the 30 women evaluated, 8 were identified as having PCOS (6 women reported a previous PCOS diagnosis and 2 women were newly diagnosed), resulting in a prevalence of 26.7%.
CONCLUSIONS:
We concluded that PCOS occurs frequently among premenopausal women with type 2 diabetes.
AD
Division of Endocrinology and Metabolism, Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298-0111, USA.
PMID